BCYC - Bicycle Therapeutics Plc - ADR
IEX Last Trade
21.515
-0.145 -0.674%
Share volume: 63,602
Last Updated: Fri 30 Aug 2024 09:59:21 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$21.66
-0.15
-0.67%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-03 | 2023-02-28 | 2023-05-04 | 2023-08-03 | 2023-11-02 | 2024-02-20 | 2024-05-02 | |
| Total revenue | 4.378 M | 3.040 M | 3.185 M | 4.896 M | 11.397 M | 5.352 M | 5.331 M | 19.530 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 4.378 M | 3.040 M | 3.185 M | 4.896 M | 11.397 M | 5.352 M | 5.331 M | 19.530 M | |
| -30.56% | 4.77% | 53.72% | 132.78% | -53.04% | -0.39% | 266.35% | |||
| Operating expenses | 31.678 M | 32.799 M | 35.396 M | 46.699 M | 54.508 M | 56.149 M | 59.566 M | 51.246 M | |
| Selling general and admin | 11.824 M | 10.047 M | 10.677 M | 14.488 M | 14.788 M | 16.281 M | 14.869 M | 16.382 M | |
| Research and development | 19.854 M | 22.752 M | 24.719 M | 32.211 M | 39.720 M | 39.868 M | 44.697 M | 34.864 M | |
| Total expenses | 31.678 M | 32.799 M | 35.396 M | 46.699 M | 54.508 M | 56.149 M | 59.566 M | 51.246 M | |
| 3.54% | 7.92% | 31.93% | 16.72% | 3.01% | 6.09% | -13.97% | |||
| Operating income | -27.300 M | -29.759 M | -32.211 M | -41.803 M | -43.111 M | -50.797 M | -54.235 M | -31.716 M | |
| Ebit | -27.300 M | -29.759 M | -32.211 M | -41.803 M | -43.111 M | -50.797 M | -54.235 M | -31.716 M | |
| Pretax income | -27.275 M | -28.585 M | -30.398 M | -39.682 M | -43.120 M | -47.626 M | -48.779 M | -26.913 M | |
| 4.80% | 6.34% | 30.54% | 8.66% | 10.45% | 2.42% | -44.83% | |||
| Income tax | -447.000 K | -238.000 K | -420.000 K | -618.000 K | -517.000 K | 2.272 M | 320.000 K | -350.000 K | |
| Net income basic | -26.828 M | -28.347 M | -29.978 M | -39.064 M | -42.603 M | -49.898 M | -49.099 M | -26.563 M | |
| -5.66% | -5.75% | -30.31% | -9.06% | -17.12% | 1.60% | 45.90% | |||
| Net income | -26.828 M | -28.347 M | -29.978 M | -39.064 M | -42.603 M | -49.898 M | -49.099 M | -26.563 M | |
| -5.66% | -5.75% | -30.31% | -9.06% | -17.12% | 1.60% | 45.90% |